T1	Outcome 329 346	urinary excretion
T2	Outcome 277 324	areas under 24-hour plasma concentration curves
T3	Outcome 261 274	Plasma levels
T4	Outcome 0 23	Maximal bioavailability
T5	Intervention 27 65	digoxin from tablets and oral solution
T6	Intervention 135 163	digoxin from Lanoxin tablets
T7	Intervention 186 258	international chemical reference substance digoxin from an oral solution
T8	Observation 352 359	similar
T9	Intervention 363 380	both formulations
T10	Count 399 418	78 % of the digoxin
T11	Intervention 454 461	tablets
T12	Intervention 480 488	solution
T13	Count 466 470	76 %
T14	Outcome 436 444	absorbed
T15	Outcome 497 533	dissolution in the intestinal fluids
T16	Observation 491 496	Rapid
T19	Intervention 587 594	tablets
T20	Outcome 121 131	absorption
T21	Outcome 172 182	absorption
T17	Outcome 556 579	digoxin bioavailability
R1	to Arg1:T9 Arg2:T8	
R2	to Arg1:T8 Arg2:T1	
R3	to Arg1:T8 Arg2:T2	
R4	to Arg1:T8 Arg2:T3	
R6	to Arg1:T10 Arg2:T14	
R5	to Arg1:T11 Arg2:T10	
R7	to Arg1:T12 Arg2:T13	
R8	to Arg1:T13 Arg2:T14	
T18	Observation 551 555	high
R9	to Arg1:T16 Arg2:T15	
R10	to Arg1:T18 Arg2:T17	
R11	to Arg1:T19 Arg2:T18	
R12	to Arg1:T19 Arg2:T16	
